EU Centralized Switch Process Needs Longer Exclusivity, More Trust - Execs
This article was originally published in The Tan Sheet
Executive Summary
Limited data protection and a lack of trust between industry and regulators are dampening enthusiasm for the European Union's centralized switch process, according to industry leaders
You may also be interested in...
GSK Urges Regulatory Changes To Pull EU Market From Doldrums
The time appears right for Rx-to-OTC switches as European Union members struggle to control expanding health budgets in the face of aging populations and the continuing global economic crisis.